Fujian Haixi Pharmaceuticals Co., Ltd. (stock code: 02637) released its monthly return for the period ended 31 October 2025, confirming that both its authorized and issued share capital remained stable during the month. The total authorized share capital was registered at 78,707,270 ordinary H shares with a par value of RMB 1 each, amounting to RMB 78,707,270.

According to the announcement, the number of issued shares also stood at 78,707,270, with no treasury shares held. No movements in share options, warrants, convertible securities, or other share issuance arrangements were reported. The data reflects the share balance as of 20 October 2025, the date on which the H shares commenced listing on the Main Board of The Stock Exchange of Hong Kong Limited.